Novo's Victoza Drug For Diabetes Shows Promise in Alzheimer's Treatment, But Misses Primary Goal A new study finds that Novo Nordisk’s drug shows signs of cognitive benefit, but no improvement in brain metabolism is seen relative to the placebo. by Joseph Henry